Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adenocarcinoma of the Stomach / Gastroesophageal”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT03122548
What this trial is testing

Safety and Efficacy of CRS-207 With Pembrolizumab in Gastric, Gastroesophageal Junction or Esophageal Cancers

Who this might be right for
Gastric AdenocarcinomaGastroesophageal Junction AdenocarcinomaEsophageal Adenocarcinoma
Aduro Biotech, Inc. 5
Testing effectiveness (Phase 2)Ended earlyNCT05567835
What this trial is testing

Total Neoadjuvant Chemotherapy With FLOT VS Standard Perioperative FLOT in Patients With Gastric or GEJ Cancer

Who this might be right for
Gastric AdenocarcinomaGastroesophageal Junction Adenocarcinoma
Baylor College of Medicine 3
Testing effectiveness (Phase 2)UnknownNCT05608785
What this trial is testing

Single-center, Multi-cohort Exploratory Phase Ib/II Clinical Study of First-line Treatment of Unresectable Locally Advanced/Advanced Adenocarcinoma of the Stomach or Gastroesophageal Junction Based on Different Genotypes

Who this might be right for
Gastric CancerGastroesophageal-junction Cancer
Henan Cancer Hospital 45
Large-scale testing (Phase 3)Looking for participantsNCT07315750
What this trial is testing

Disitamab Vedotin Combined With Trastuzumab and Tislelizumab Versus Chemotherapy Combined With Trastuzumab With or Without Pembrolizumab in HER2-high Expression Advanced Gastric or Gastroesophageal Junction Adenocarcinoma.

Who this might be right for
Gastric Carcinoma
RemeGen Co., Ltd. 555
Testing effectiveness (Phase 2)Active Not RecruitingNCT06739161
What this trial is testing

Sintilimab in Combination with Chemotherapy ± Local Treatment for Om-G/GEJ

Who this might be right for
Gastroesophageal Junction Adenocarcinoma
Jiangsu Cancer Institute & Hospital 120
Early research (Phase 1)Study completedNCT03538028
What this trial is testing

A Safety and Tolerability Study of INCAGN02385 in Select Advanced Malignancies

Who this might be right for
Cervical CancerMicrosatellite Instability (MSI)-High Endometrial CancerGastric Cancer (Including Stomach and Gastroesophageal Junction [GEJ])+14 more
Incyte Biosciences International Sàrl 22
Not applicableNot Yet RecruitingNCT07139587
What this trial is testing

The Efficacy and Safety of Iparomlimab/Tuvonralimab (Anti PD-1/CTLA-4) Combined With Albumin-bound Paclitaxel in Second-line Treatment of Patients With Advanced Gastric/Gastroesophageal Junction Adenocarcinoma

Who this might be right for
Gastric CancerGastroesophageal Junction Adenocarcinoma
Qingxia Li 30
Not applicableNot Yet RecruitingNCT07260734
What this trial is testing

AUGMENTED RESPONSE OF VOLATILE BIOMARKERS IN THE ASSESSMENT OF OESOPHAGOGASTRIC CANCER (AROMA2)

Who this might be right for
OESOPHAGO-GASTRIC CARCINOMAOesophageal AdenocarcinomaGastric Adenocarcinoma and Gastroesophageal Junction Adenocarcinoma+5 more
Imperial College London 6,000
Not applicableStudy completedNCT01939275
What this trial is testing

64Cu DOTA-Trastuzumab PET/CT in Studying Patients With Gastric Cancer

Who this might be right for
Adenocarcinoma of the Gastroesophageal JunctionDiffuse Adenocarcinoma of the StomachIntestinal Adenocarcinoma of the Stomach+10 more
City of Hope Medical Center 8
Testing effectiveness (Phase 2)Ended earlyNCT02485834
What this trial is testing

FDG-PET Directed Treatment in Improving Response in Patients With Locally Advanced Stomach or Gastroesophageal Junction Cancer

Who this might be right for
Adenocarcinoma of the Gastroesophageal JunctionGastric AdenocarcinomaGastric Cancer
Alliance for Clinical Trials in Oncology 5
Early research (Phase 1)Looking for participantsNCT06266299
What this trial is testing

KK2269 in Adult Participants With Solid Tumors

Who this might be right for
Advanced Solid TumorMetastatic Solid TumorGastric Adenocarcinoma+3 more
Kyowa Kirin Co., Ltd. 101
Testing effectiveness (Phase 2)Study completedNCT01231399
What this trial is testing

Everolimus and Combination Chemotherapy in Treating Patients With Metastatic Stomach or Esophageal Cancer

Who this might be right for
Adenocarcinoma of the EsophagusAdenocarcinoma of the Gastroesophageal JunctionDiffuse Adenocarcinoma of the Stomach+6 more
City of Hope Medical Center 6
Early research (Phase 1)Not Yet RecruitingNCT07358884
What this trial is testing

First in Human Study of QLS5316 in Solid Tumors

Who this might be right for
Solid TumorsColorectal CancerGastric Cancer or Gastroesophageal Junction Adenocarcinoma+2 more
Qilu Pharmaceutical Co., Ltd. 300
Testing effectiveness (Phase 2)Active Not RecruitingNCT05128487
What this trial is testing

NDI 1150-101 in Patients With Solid Tumors

Who this might be right for
Solid TumorRenal Cell Carcinoma (Kidney Cancer)Gastric and Gastroesophageal Junction (GEJ) Adenocarcinoma+1 more
Nimbus Saturn, Inc. 106
Testing effectiveness (Phase 2)Active Not RecruitingNCT03979131
What this trial is testing

Phase II Study of Avelumab Plus Chemotherapy in the Peri-operative Treatment for Patients With Resectable Gastric Cancer (GC) or Gastroesophageal Junction Cancer (GEJC)

Who this might be right for
Gastroesophageal Junction AdenocarcinomaStomach Neoplasms
Vall d'Hebron Institute of Oncology 40
Not applicableStudy completedNCT03986502
What this trial is testing

Financial Navigation Intervention in Improving Financial and Clinical Outcomes in Patients With Newly Diagnosed Gastric or Gastroesophageal Junction Adenocarcinoma

Who this might be right for
Gastric AdenocarcinomaGastroesophageal Junction Adenocarcinoma
Fred Hutchinson Cancer Center 30
Not applicableLooking for participantsNCT06902545
What this trial is testing

Observe the Safety of VYLOY (Zolbetuximab) in People in South Korea With Gastric or Gastroesophageal Junction Cancer.

Who this might be right for
Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or CancerLocally Advanced Unresectable Gastric Adenocarcinoma or CancerMetastatic Gastric Adenocarcinoma or Cancer+1 more
Astellas Pharma Korea, Inc.
Testing effectiveness (Phase 2)Study completedNCT00054457
What this trial is testing

Docetaxel and Capecitabine in Treating Patients With Metastatic Cancer of the Stomach or Gastroesophageal Junction

Who this might be right for
Esophageal CancerGastric Cancer
Alliance for Clinical Trials in Oncology 46
Large-scale testing (Phase 3)Not Yet RecruitingNCT07818070
What this trial is testing

A Trial of ONO-4578 Versus Placebo in Combination With Nivolumab and Chemotherapy in Participants With Gastric Cancer, Esophagogastric Junction Cancer, or Esophageal Adenocarcinoma

Who this might be right for
Gastric CancerEsophagogastric Junction CancerEsophageal Adenocarcinoma
Ono Pharmaceutical Co., Ltd. 600
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07655661
What this trial is testing

Mannatide Combined With CAPOX and Tislelizumab for Advanced Gastric Cancer.

Who this might be right for
Gastric AdenocarcinomaGastroesophageal Junction Adenocarcinoma
Ming Liu 52
Next Page
377